Relmada Therapeutics shares owned by Acadian Asset Management
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Acadian Asset Management
from 13F filings
Historical chart of Acadian Asset Management investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Acadian Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.2M | 583k | 2.01 |
| 2025-06-30 | $371k | 620k | 0.60 |
| 2025-03-31 | $329k | 1.2M | 0.27 |
| 2024-12-31 | $636k | 1.2M | 0.52 |
| 2024-09-30 | $3.8M | 1.2M | 3.24 |
| 2024-06-30 | $3.6M | 1.2M | 3.00 |
| 2024-03-31 | $5.5M | 1.2M | 4.65 |
| 2023-09-30 | $3.5M | 1.2M | 3.00 |
| 2023-06-30 | $3.0M | 1.2M | 2.46 |
| 2023-03-31 | $2.8M | 1.2M | 2.26 |
| 2022-12-31 | $3.8M | 1.1M | 3.48 |